This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Guideline

. 2003 Dec;30(12):BP132-9.

doi: 10.1007/s00259-003-1357-0.

131I/123I-metaiodobenzylguanidine (MIBG) scintigraphy: procedure guidelines for tumour imaging

Emilio Bombardieri¹, Cumali Aktolun, Richard P Baum, Angelika Bishof-Delaloye, John Buscombe, Jean François Chatal, Lorenzo Maffioli, Roy Moncayo, Luc Mortelmans, Sven N Reske

Affiliations

PMID: 14989227
DOI: 10.1007/s00259-003-1357-0

Guideline

131I/123I-metaiodobenzylguanidine (MIBG) scintigraphy: procedure guidelines for tumour imaging

Emilio Bombardieri et al. Eur J Nucl Med Mol Imaging. 2003 Dec.

. 2003 Dec;30(12):BP132-9.

doi: 10.1007/s00259-003-1357-0.

Authors

Emilio Bombardieri¹, Cumali Aktolun, Richard P Baum, Angelika Bishof-Delaloye, John Buscombe, Jean François Chatal, Lorenzo Maffioli, Roy Moncayo, Luc Mortelmans, Sven N Reske

Affiliation

¹ Istituto Nazionale per lo Studio e la Cura dei Tumori, Milano, Italy. mednuc@istitutotumori.mi.it

PMID: 14989227
DOI: 10.1007/s00259-003-1357-0

No abstract available

PubMed Disclaimer

Similar articles

67Ga scintigraphy: procedure guidelines for tumour imaging.
Bombardieri E, Aktolun C, Baum RP, Bishof-Delaloye A, Buscombe J, Chatal JF, Maffioli L, Moncayo R, Mortelmans L, Reske SN. Bombardieri E, et al. Eur J Nucl Med Mol Imaging. 2003 Dec;30(12):BP125-31. doi: 10.1007/s00259-003-1356-1. Eur J Nucl Med Mol Imaging. 2003. PMID: 14989225 No abstract available.
FDG-PET: procedure guidelines for tumour imaging.
Bombardieri E, Aktolun C, Baum RP, Bishof-Delaloye A, Buscombe J, Chatal JF, Maffioli L, Moncayo R, Mortelmans L, Reske SN. Bombardieri E, et al. Eur J Nucl Med Mol Imaging. 2003 Dec;30(12):BP115-24. doi: 10.1007/s00259-003-1355-2. Eur J Nucl Med Mol Imaging. 2003. PMID: 14989224 No abstract available.
111In-pentetreotide scintigraphy: procedure guidelines for tumour imaging.
Bombardieri E, Aktolun C, Baum RP, Bishof-Delaloye A, Buscombe J, Chatal JF, Maffioli L, Moncayo R, Mortelmans L, Reske SN. Bombardieri E, et al. Eur J Nucl Med Mol Imaging. 2003 Dec;30(12):BP140-7. doi: 10.1007/s00259-003-1358-z. Eur J Nucl Med Mol Imaging. 2003. PMID: 14989228 No abstract available.
Nuclear medicine imaging of neuroendocrine tumours.
Bombardieri E, Maccauro M, De Deckere E, Savelli G, Chiti A. Bombardieri E, et al. Ann Oncol. 2001;12 Suppl 2:S51-61. doi: 10.1093/annonc/12.suppl_2.s51. Ann Oncol. 2001. PMID: 11762353 Review.
The good laboratory practice and good clinical practice requirements for the production of radiopharmaceuticals in clinical research.
De Vos FJ, De Decker M, Dierckx RA. De Vos FJ, et al. Nucl Med Commun. 2005 Jul;26(7):575-9. doi: 10.1097/01.mnm.0000169377.07518.f9. Nucl Med Commun. 2005. PMID: 15942476 Review.

See all similar articles

Cited by

Diagnostic cutoff points for ¹²³I-MIBG myocardial scintigraphy in a Caucasian population with Parkinson's disease.
Muxí A, Paredes P, Navales I, Valldeoriola F, Gaig C, Lomeña F, de la Cerda A, Solà O, Domenech B, Tolosa E, Pons F. Muxí A, et al. Eur J Nucl Med Mol Imaging. 2011 Jun;38(6):1139-46. doi: 10.1007/s00259-011-1754-8. Epub 2011 Mar 4. Eur J Nucl Med Mol Imaging. 2011. PMID: 21373765
Imaging in targeted delivery of therapy to cancer.
Dancey G, Begent RH, Meyer T. Dancey G, et al. Target Oncol. 2009 Sep;4(3):201-17. doi: 10.1007/s11523-009-0119-8. Epub 2009 Oct 8. Target Oncol. 2009. PMID: 19838639 Review.
Sensitivity of surveillance studies for detecting asymptomatic and unsuspected relapse of high-risk neuroblastoma.
Kushner BH, Kramer K, Modak S, Cheung NK. Kushner BH, et al. J Clin Oncol. 2009 Mar 1;27(7):1041-6. doi: 10.1200/JCO.2008.17.6107. Epub 2009 Jan 26. J Clin Oncol. 2009. PMID: 19171710 Free PMC article.
Functional imaging in phaeochromocytoma and neuroblastoma with 68Ga-DOTA-Tyr 3-octreotide positron emission tomography and 123I-metaiodobenzylguanidine.
Kroiss A, Putzer D, Uprimny C, Decristoforo C, Gabriel M, Santner W, Kranewitter C, Warwitz B, Waitz D, Kendler D, Virgolini IJ. Kroiss A, et al. Eur J Nucl Med Mol Imaging. 2011 May;38(5):865-73. doi: 10.1007/s00259-010-1720-x. Epub 2011 Jan 29. Eur J Nucl Med Mol Imaging. 2011. PMID: 21279352
Iodine-131MIBG SPECT/CT in neuroendocrine tumours: An institutional experience.
Verma P, Chanadana, Hephzibah J, Shanthly N, Oommen R. Verma P, et al. Indian J Nucl Med. 2012 Oct;27(4):246-8. doi: 10.4103/0972-3919.115396. Indian J Nucl Med. 2012. PMID: 24019655 Free PMC article.

See all "Cited by" articles

References

1. Eur J Nucl Med. 1998 Jan;25(1):79-83 - PubMed
1. J Nucl Med. 1994 May;35(5):803-10 - PubMed
1. Q J Nucl Med. 2003 Mar;47(1):31-40 - PubMed
1. Ann ICRP. 1991;22(3):1-28, v-xxiv - PubMed
1. Nucl Med Commun. 2002 Aug;23(8):735-41 - PubMed

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Springer